| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | SNED1 VLDLR SCUBE1 STAB2 FBN1 SCUBE2 SUSD1 DLL4 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 ITGB1 LRP1B LDLR FBN3 EGFEM1P NOTCH2 LRP8 | 9.64e-16 | 749 | 52 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.20e-10 | 16 | 52 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.25e-09 | 188 | 52 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.94e-09 | 21 | 52 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 6.65e-08 | 4 | 52 | 3 | GO:0030229 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 8.66e-08 | 85 | 52 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 2.02e-06 | 35 | 52 | 4 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 2.02e-06 | 35 | 52 | 4 | GO:0071814 | |
| GeneOntologyMolecularFunction | reelin receptor activity | 6.65e-06 | 2 | 52 | 2 | GO:0038025 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.84e-05 | 20 | 52 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.90e-05 | 73 | 52 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | Notch binding | 4.66e-05 | 27 | 52 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 7.84e-05 | 547 | 52 | 8 | GO:0048018 | |
| GeneOntologyMolecularFunction | structural molecule activity | 8.55e-05 | 891 | 52 | 10 | GO:0005198 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 8.57e-05 | 554 | 52 | 8 | GO:0030546 | |
| GeneOntologyMolecularFunction | integrin binding | 9.09e-05 | 175 | 52 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | microfibril binding | 9.91e-05 | 6 | 52 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 1.78e-04 | 616 | 52 | 8 | GO:0030545 | |
| GeneOntologyMolecularFunction | cytokine binding | 7.42e-04 | 157 | 52 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 9.91e-04 | 18 | 52 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | collagen binding | 1.23e-03 | 81 | 52 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.42e-03 | 85 | 52 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 2.24e-03 | 27 | 52 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | laminin binding | 3.54e-03 | 34 | 52 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 3.77e-03 | 120 | 52 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 4.20e-03 | 1233 | 52 | 9 | GO:0140677 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 5.18e-03 | 268 | 52 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | frizzled binding | 5.36e-03 | 42 | 52 | 2 | GO:0005109 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | FBN1 CRIM1 DLL4 ADAM9 SCUBE3 SHISA2 LTBP1 LTBP2 ITGB1 IL17F NOTCH2 STAT3 LRP8 | 1.29e-07 | 850 | 52 | 13 | GO:0071363 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | FBN1 CRIM1 ADAM9 SCUBE3 LTBP1 LTBP2 ITGB1 IL17F NOTCH2 STAT3 | 1.39e-07 | 445 | 52 | 10 | GO:0141091 |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 1.63e-07 | 50 | 52 | 5 | GO:1905314 | |
| GeneOntologyBiologicalProcess | response to growth factor | FBN1 CRIM1 DLL4 ADAM9 SCUBE3 SHISA2 LTBP1 LTBP2 ITGB1 IL17F NOTCH2 STAT3 LRP8 | 2.00e-07 | 883 | 52 | 13 | GO:0070848 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | FBN1 CRIM1 ADAM9 SCUBE3 LTBP1 LTBP2 ITGB1 IL17F NOTCH2 STAT3 | 2.90e-07 | 482 | 52 | 10 | GO:0007178 |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 5.26e-07 | 63 | 52 | 5 | GO:0003179 | |
| GeneOntologyBiologicalProcess | reelin-mediated signaling pathway | 8.39e-07 | 8 | 52 | 3 | GO:0038026 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 1.18e-06 | 74 | 52 | 5 | GO:0002011 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.54e-06 | 78 | 52 | 5 | GO:0003170 | |
| GeneOntologyBiologicalProcess | circulatory system development | ADAMTS19 SCUBE1 STAB2 FBN1 TIE1 APOLD1 DLL4 WNT7A JAG1 LTBP1 ITGB1 IL17F LDLR NOTCH2 STAT3 | 1.65e-06 | 1442 | 52 | 15 | GO:0072359 |
| GeneOntologyBiologicalProcess | blood vessel development | STAB2 TIE1 APOLD1 DLL4 WNT7A JAG1 LTBP1 ITGB1 IL17F LDLR NOTCH2 STAT3 | 2.53e-06 | 929 | 52 | 12 | GO:0001568 |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 2.77e-06 | 39 | 52 | 4 | GO:0003180 | |
| GeneOntologyBiologicalProcess | vasculature development | STAB2 TIE1 APOLD1 DLL4 WNT7A JAG1 LTBP1 ITGB1 IL17F LDLR NOTCH2 STAT3 | 3.91e-06 | 969 | 52 | 12 | GO:0001944 |
| GeneOntologyBiologicalProcess | regulation of osteoclast development | 4.25e-06 | 13 | 52 | 3 | GO:2001204 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | STAB2 TIE1 APOLD1 DLL4 WNT7A JAG1 ITGB1 IL17F LDLR NOTCH2 STAT3 | 4.81e-06 | 817 | 52 | 11 | GO:0048514 |
| GeneOntologyBiologicalProcess | aortic valve development | 5.42e-06 | 46 | 52 | 4 | GO:0003176 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | FBN1 CRIM1 TIE1 ADAM9 SCUBE3 LRP4 SHISA2 LTBP1 LTBP2 ITGB1 IL17F NOTCH2 STAT3 | 5.45e-06 | 1186 | 52 | 13 | GO:0007167 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 5.69e-06 | 276 | 52 | 7 | GO:0007179 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 7.29e-06 | 405 | 52 | 8 | GO:0033674 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | VLDLR RELN FBN1 MCPH1 TIE1 ADAM9 NSD1 LRP4 LTF ITGB1 LDLR NOTCH2 STAT3 LRP8 | 7.51e-06 | 1421 | 52 | 14 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | VLDLR RELN FBN1 MCPH1 TIE1 ADAM9 NSD1 LRP4 LTF ITGB1 LDLR NOTCH2 STAT3 LRP8 | 7.64e-06 | 1423 | 52 | 14 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 8.26e-06 | 412 | 52 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | angiogenesis | 9.14e-06 | 708 | 52 | 10 | GO:0001525 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | 9.62e-06 | 879 | 52 | 11 | GO:0045937 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | 9.62e-06 | 879 | 52 | 11 | GO:0010562 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.02e-05 | 198 | 52 | 6 | GO:0048813 | |
| GeneOntologyBiologicalProcess | ventral spinal cord development | 1.29e-05 | 57 | 52 | 4 | GO:0021517 | |
| GeneOntologyBiologicalProcess | regulation of cell development | RELN FBN1 DLL4 WNT7A JAG1 LRP4 LTF ITGB1 LDLR NOTCH2 STAT3 LRP8 | 1.35e-05 | 1095 | 52 | 12 | GO:0060284 |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 1.67e-05 | 20 | 52 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 2.04e-05 | 336 | 52 | 7 | GO:0071560 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 2.11e-05 | 780 | 52 | 10 | GO:0042327 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 2.12e-05 | 338 | 52 | 7 | GO:0045165 | |
| GeneOntologyBiologicalProcess | osteoclast development | 2.25e-05 | 22 | 52 | 3 | GO:0036035 | |
| GeneOntologyBiologicalProcess | bone cell development | 2.25e-05 | 22 | 52 | 3 | GO:0098751 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.33e-05 | 343 | 52 | 7 | GO:0071559 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 2.65e-05 | 350 | 52 | 7 | GO:0045860 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 2.88e-05 | 490 | 52 | 8 | GO:0051347 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 2.95e-05 | 24 | 52 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | tube development | STAB2 FBN1 TIE1 APOLD1 DLL4 WNT7A JAG1 MUC19 ITGB1 IL17F LDLR NOTCH2 STAT3 | 3.26e-05 | 1402 | 52 | 13 | GO:0035295 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.73e-05 | 4 | 52 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 4.10e-05 | 515 | 52 | 8 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | VLDLR RELN FBN1 MCPH1 TIE1 ADAM9 NSD1 LRP4 LTF ITGB1 NOTCH2 LRP8 | 4.14e-05 | 1226 | 52 | 12 | GO:0042325 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 4.83e-05 | 686 | 52 | 9 | GO:0043549 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | VLDLR RELN FBN1 ADAM9 WNT7A LRP4 LTF ITGB1 IL17F LDLR NOTCH2 STAT3 LRP8 | 4.90e-05 | 1458 | 52 | 13 | GO:0051247 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ADAMTS19 SCUBE2 DLL4 WNT7A JAG1 WNT8B MUC19 LRP4 LTF TECTA NOTCH2 STAT3 | 5.79e-05 | 1269 | 52 | 12 | GO:0009887 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | RELN STAB2 TIE1 APOLD1 DLL4 ADAM9 WNT7A JAG1 ITGB1 IL17F NOTCH2 STAT3 LRP8 | 5.84e-05 | 1483 | 52 | 13 | GO:0048646 |
| GeneOntologyBiologicalProcess | positive regulation of osteoblast differentiation | 7.16e-05 | 88 | 52 | 4 | GO:0045669 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | 7.32e-05 | 724 | 52 | 9 | GO:0001934 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | STAB2 TIE1 APOLD1 DLL4 WNT7A JAG1 ITGB1 IL17F LDLR NOTCH2 STAT3 | 9.27e-05 | 1125 | 52 | 11 | GO:0035239 |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 9.29e-05 | 6 | 52 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast development | 9.29e-05 | 6 | 52 | 2 | GO:2001205 | |
| GeneOntologyBiologicalProcess | endothelium development | 9.40e-05 | 182 | 52 | 5 | GO:0003158 | |
| GeneOntologyBiologicalProcess | heart development | 1.03e-04 | 757 | 52 | 9 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 1.21e-04 | 192 | 52 | 5 | GO:0045667 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.41e-04 | 615 | 52 | 8 | GO:0001501 | |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 1.53e-04 | 107 | 52 | 4 | GO:0009953 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 1.58e-04 | 625 | 52 | 8 | GO:0051960 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 1.71e-04 | 810 | 52 | 9 | GO:0051338 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 1.73e-04 | 8 | 52 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 1.73e-04 | 8 | 52 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 1.84e-04 | 210 | 52 | 5 | GO:0007219 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 1.90e-04 | 1220 | 52 | 11 | GO:0051093 | |
| GeneOntologyBiologicalProcess | dendrite development | 1.90e-04 | 335 | 52 | 6 | GO:0016358 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.92e-04 | 212 | 52 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 1.95e-04 | 114 | 52 | 4 | GO:0008593 | |
| GeneOntologyBiologicalProcess | positive regulation of smoothened signaling pathway | 1.99e-04 | 45 | 52 | 3 | GO:0045880 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | 2.12e-04 | 1028 | 52 | 10 | GO:0043085 | |
| GeneOntologyBiologicalProcess | spinal cord development | 2.30e-04 | 119 | 52 | 4 | GO:0021510 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.30e-04 | 347 | 52 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | cell fate determination | 2.72e-04 | 50 | 52 | 3 | GO:0001709 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 2.77e-04 | 10 | 52 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | positive regulation of chondrocyte proliferation | 2.77e-04 | 10 | 52 | 2 | GO:1902732 | |
| GeneOntologyBiologicalProcess | podocyte development | 2.77e-04 | 10 | 52 | 2 | GO:0072015 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 3.04e-04 | 875 | 52 | 9 | GO:0045596 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 3.24e-04 | 53 | 52 | 3 | GO:0045747 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 3.32e-04 | 131 | 52 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 3.38e-04 | 11 | 52 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | artery development | 3.52e-04 | 133 | 52 | 4 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 3.62e-04 | 134 | 52 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 4.12e-04 | 387 | 52 | 6 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 4.59e-04 | 395 | 52 | 6 | GO:0050803 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | 4.60e-04 | 1133 | 52 | 10 | GO:0001932 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 4.78e-04 | 13 | 52 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 4.78e-04 | 13 | 52 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | 5.02e-04 | 937 | 52 | 9 | GO:0031401 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 5.24e-04 | 405 | 52 | 6 | GO:0042742 | |
| GeneOntologyBiologicalProcess | bone development | 5.26e-04 | 264 | 52 | 5 | GO:0060348 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 5.28e-04 | 748 | 52 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 5.59e-04 | 410 | 52 | 6 | GO:0031589 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 5.82e-04 | 270 | 52 | 5 | GO:0007160 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 6.74e-04 | 158 | 52 | 4 | GO:0045446 | |
| GeneOntologyBiologicalProcess | central nervous system development | 7.07e-04 | 1197 | 52 | 10 | GO:0007417 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 7.23e-04 | 161 | 52 | 4 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 7.23e-04 | 161 | 52 | 4 | GO:0003231 | |
| GeneOntologyBiologicalProcess | embryo development | TIE1 DLL4 WNT7A JAG1 WNT8B NSD1 LRP4 TECTA ITGB1 LRP1B NOTCH2 | 7.66e-04 | 1437 | 52 | 11 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 7.79e-04 | 288 | 52 | 5 | GO:0045637 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 8.14e-04 | 611 | 52 | 7 | GO:0045859 | |
| GeneOntologyBiologicalProcess | layer formation in cerebral cortex | 8.28e-04 | 17 | 52 | 2 | GO:0021819 | |
| GeneOntologyBiologicalProcess | positive regulation of CREB transcription factor activity | 9.29e-04 | 18 | 52 | 2 | GO:0032793 | |
| GeneOntologyBiologicalProcess | osteoblast differentiation | 9.64e-04 | 302 | 52 | 5 | GO:0001649 | |
| GeneOntologyCellularComponent | extracellular matrix | SNED1 ADAMTS19 RELN FBN1 FCGBP VWF COL19A1 WNT7A LTBP1 LTBP2 TECTA ITGB1 FBN3 | 6.74e-09 | 656 | 53 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SNED1 ADAMTS19 RELN FBN1 FCGBP VWF COL19A1 WNT7A LTBP1 LTBP2 TECTA ITGB1 FBN3 | 6.99e-09 | 658 | 53 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | cell surface | VLDLR SCUBE1 STAB2 VWF SCUBE2 ADAM9 WNT7A SCUBE3 LRP4 ASTN1 LTF ITGB1 LDLR NOTCH2 LRP8 | 6.45e-08 | 1111 | 53 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | microfibril | 4.32e-06 | 13 | 53 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.68e-04 | 109 | 53 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 3.20e-04 | 519 | 53 | 7 | GO:0009897 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.63e-04 | 530 | 53 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | receptor complex | 6.29e-04 | 581 | 53 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 6.42e-04 | 155 | 53 | 4 | GO:0098685 | |
| GeneOntologyCellularComponent | side of membrane | 1.52e-03 | 875 | 53 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | lipoprotein particle | 5.57e-03 | 44 | 53 | 2 | GO:1990777 | |
| GeneOntologyCellularComponent | plasma lipoprotein particle | 5.57e-03 | 44 | 53 | 2 | GO:0034358 | |
| GeneOntologyCellularComponent | plasma membrane raft | 6.17e-03 | 147 | 53 | 3 | GO:0044853 | |
| GeneOntologyCellularComponent | protein-lipid complex | 6.34e-03 | 47 | 53 | 2 | GO:0032994 | |
| HumanPheno | Aortic valve stenosis | 4.01e-07 | 113 | 23 | 7 | HP:0001650 | |
| HumanPheno | Foot oligodactyly | 1.30e-05 | 11 | 23 | 3 | HP:0001849 | |
| HumanPheno | Abnormal aortic valve physiology | 1.42e-05 | 192 | 23 | 7 | HP:0031652 | |
| HumanPheno | Abnormal pulmonary artery morphology | 1.98e-05 | 133 | 23 | 6 | HP:0030966 | |
| HumanPheno | Abnormal heart valve physiology | 3.33e-05 | 403 | 23 | 9 | HP:0031653 | |
| HumanPheno | Microspherophakia | 1.16e-04 | 4 | 23 | 2 | HP:0030961 | |
| HumanPheno | Abnormal pulmonary valve morphology | 1.85e-04 | 198 | 23 | 6 | HP:0001641 | |
| HumanPheno | Iridodonesis | 1.93e-04 | 5 | 23 | 2 | HP:0100693 | |
| HumanPheno | Spherophakia | 1.93e-04 | 5 | 23 | 2 | HP:0034375 | |
| HumanPheno | Abnormal aortic valve morphology | 1.96e-04 | 289 | 23 | 7 | HP:0001646 | |
| HumanPheno | Abnormal atrioventricular valve physiology | 2.91e-04 | 215 | 23 | 6 | HP:0031650 | |
| HumanPheno | Aplasia of the toes | 2.95e-04 | 74 | 23 | 4 | HP:0011306 | |
| HumanPheno | Absent toe | 2.95e-04 | 74 | 23 | 4 | HP:0010760 | |
| HumanPheno | Pulmonic stenosis | 3.08e-04 | 138 | 23 | 5 | HP:0001642 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 3.20e-04 | 538 | 23 | 9 | HP:0005927 | |
| HumanPheno | Dolichocephaly | 3.22e-04 | 219 | 23 | 6 | HP:0000268 | |
| HumanPheno | Brachydactyly | 3.30e-04 | 670 | 23 | 10 | HP:0001156 | |
| HumanPheno | Short digit | 3.38e-04 | 672 | 23 | 10 | HP:0011927 | |
| HumanPheno | Bowing of the long bones | 3.41e-04 | 316 | 23 | 7 | HP:0006487 | |
| HumanPheno | Brachydactyly (hand) | 3.80e-04 | 430 | 23 | 8 | HP:0100667 | |
| HumanPheno | Anomaly of the limb diaphyses | 3.83e-04 | 322 | 23 | 7 | HP:0006504 | |
| HumanPheno | Oligodactyly | 4.02e-04 | 33 | 23 | 3 | HP:0012165 | |
| HumanPheno | Increased arm span | 4.04e-04 | 7 | 23 | 2 | HP:0012771 | |
| HumanPheno | Abnormal fingernail morphology | 4.19e-04 | 230 | 23 | 6 | HP:0001231 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 5.10e-04 | 572 | 23 | 9 | HP:0006496 | |
| HumanPheno | Abnormal diaphysis morphology | 5.64e-04 | 343 | 23 | 7 | HP:0000940 | |
| HumanPheno | Abnormal heart valve morphology | 6.27e-04 | 588 | 23 | 9 | HP:0001654 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 6.37e-04 | 350 | 23 | 7 | HP:0006705 | |
| HumanPheno | Heart murmur | 6.61e-04 | 39 | 23 | 3 | HP:0030148 | |
| HumanPheno | Abnormal pulmonary valve physiology | 6.65e-04 | 163 | 23 | 5 | HP:0031654 | |
| HumanPheno | Peripheral pulmonary artery stenosis | 7.13e-04 | 40 | 23 | 3 | HP:0004969 | |
| HumanPheno | Bowing of the legs | 7.13e-04 | 254 | 23 | 6 | HP:0002979 | |
| HumanPheno | Triangular face | 7.43e-04 | 167 | 23 | 5 | HP:0000325 | |
| HumanPheno | Abnormal toenail morphology | 7.43e-04 | 167 | 23 | 5 | HP:0008388 | |
| HumanPheno | Long nose | 7.67e-04 | 41 | 23 | 3 | HP:0003189 | |
| HumanPheno | Abnormal heart sound | 8.23e-04 | 42 | 23 | 3 | HP:0031657 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 8.34e-04 | 366 | 23 | 7 | HP:0006265 | |
| HumanPheno | Nail dysplasia | 8.75e-04 | 264 | 23 | 6 | HP:0002164 | |
| MousePheno | fused phalanges | 1.70e-05 | 16 | 45 | 3 | MP:0008730 | |
| MousePheno | abnormal bone trabecula morphology | 6.74e-05 | 134 | 45 | 5 | MP:0010867 | |
| MousePheno | decreased bone trabecula number | 7.36e-05 | 70 | 45 | 4 | MP:0010869 | |
| MousePheno | abnormal phalanx morphology | 1.02e-04 | 76 | 45 | 4 | MP:0005306 | |
| MousePheno | abnormal posture | 1.20e-04 | 243 | 45 | 6 | MP:0001504 | |
| MousePheno | lens dislocation | 1.51e-04 | 6 | 45 | 2 | MP:0031428 | |
| MousePheno | increased embryonic neuroepithelium thickness | 2.11e-04 | 7 | 45 | 2 | MP:0012702 | |
| MousePheno | abnormal short-term spatial reference memory | 2.11e-04 | 7 | 45 | 2 | MP:0008431 | |
| MousePheno | abnormal hyaloid artery morphology | 2.11e-04 | 7 | 45 | 2 | MP:0012537 | |
| MousePheno | syndactyly | 2.22e-04 | 93 | 45 | 4 | MP:0000564 | |
| MousePheno | abnormal capillary morphology | 2.22e-04 | 93 | 45 | 4 | MP:0003658 | |
| MousePheno | abnormal bone volume | 2.24e-04 | 173 | 45 | 5 | MP:0010874 | |
| MousePheno | abnormal metacarpal bone morphology | 2.24e-04 | 37 | 45 | 3 | MP:0003073 | |
| MousePheno | abnormal blood vessel physiology | 2.41e-04 | 394 | 45 | 7 | MP:0000249 | |
| MousePheno | retina neovascularization | 2.43e-04 | 38 | 45 | 3 | MP:0008852 | |
| MousePheno | abnormal cerebellum development | 2.51e-04 | 96 | 45 | 4 | MP:0000854 | |
| MousePheno | decreased circulating unsaturated transferrin level | 2.80e-04 | 8 | 45 | 2 | MP:0011897 | |
| MousePheno | abnormal vasculature physiology | 2.81e-04 | 404 | 45 | 7 | MP:0031170 | |
| MousePheno | decreased bone volume | 2.93e-04 | 100 | 45 | 4 | MP:0010876 | |
| MousePheno | pathological neovascularization | 3.93e-04 | 108 | 45 | 4 | MP:0003711 | |
| MousePheno | decreased body fat mass | 4.30e-04 | 46 | 45 | 3 | MP:0014143 | |
| MousePheno | pericardial effusion | 4.37e-04 | 111 | 45 | 4 | MP:0005312 | |
| MousePheno | decreased circulating transferrin level | 4.49e-04 | 10 | 45 | 2 | MP:0011894 | |
| MousePheno | abnormal trabecular bone volume | 4.67e-04 | 113 | 45 | 4 | MP:0010877 | |
| MousePheno | small cerebellum | 5.68e-04 | 119 | 45 | 4 | MP:0000852 | |
| MousePheno | decreased urine protein level | 6.55e-04 | 12 | 45 | 2 | MP:0002963 | |
| MousePheno | abnormal lens topology | 6.55e-04 | 12 | 45 | 2 | MP:0020486 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | RELN COL19A1 CRIM1 MCPH1 JAG1 SHISA2 LTBP1 HERC2 ITGB1 NOTCH2 STAT3 | 6.85e-04 | 1124 | 45 | 11 | MP:0011112 |
| MousePheno | abnormal pericardium morphology | 7.47e-04 | 225 | 45 | 5 | MP:0000288 | |
| Domain | EGF | SNED1 VLDLR RELN SCUBE1 MUC3B STAB2 FBN1 FCGBP SCUBE2 TIE1 SUSD1 DLL4 ADAM23 ADAM9 JAG1 SCUBE3 LRP4 ASTN1 LTBP1 LTBP2 TECTA MUC3A LRP1B LDLR FBN3 NOTCH2 LRP8 | 7.82e-38 | 235 | 53 | 27 | SM00181 |
| Domain | EGF-like_dom | SNED1 VLDLR RELN SCUBE1 MUC3B STAB2 FBN1 FCGBP SCUBE2 TIE1 SUSD1 DLL4 ADAM23 ADAM9 JAG1 SCUBE3 LRP4 ASTN1 LTBP1 LTBP2 TECTA MUC3A LRP1B LDLR FBN3 NOTCH2 LRP8 | 4.01e-37 | 249 | 53 | 27 | IPR000742 |
| Domain | EGF_1 | SNED1 VLDLR RELN SCUBE1 MUC3B STAB2 FBN1 SCUBE2 TIE1 SUSD1 DLL4 ADAM23 ADAM9 JAG1 SCUBE3 LRP4 ASTN1 LTBP1 LTBP2 MUC3A ITGB1 LRP1B LDLR FBN3 NOTCH2 LRP8 | 6.30e-35 | 255 | 53 | 26 | PS00022 |
| Domain | EGF-like_CS | SNED1 VLDLR RELN SCUBE1 MUC3B STAB2 FBN1 SCUBE2 TIE1 SUSD1 DLL4 ADAM23 ADAM9 JAG1 SCUBE3 LRP4 ASTN1 LTBP1 LTBP2 MUC3A ITGB1 LRP1B LDLR FBN3 NOTCH2 LRP8 | 1.18e-34 | 261 | 53 | 26 | IPR013032 |
| Domain | EGF_3 | SNED1 VLDLR RELN SCUBE1 MUC3B STAB2 FBN1 SCUBE2 TIE1 SUSD1 DLL4 ADAM23 ADAM9 JAG1 SCUBE3 LRP4 ASTN1 LTBP1 LTBP2 MUC3A LRP1B LDLR FBN3 NOTCH2 LRP8 | 5.62e-34 | 235 | 53 | 25 | PS50026 |
| Domain | EGF_2 | SNED1 VLDLR RELN SCUBE1 MUC3B STAB2 FBN1 SCUBE2 TIE1 SUSD1 DLL4 ADAM23 ADAM9 JAG1 SCUBE3 LRP4 ASTN1 LTBP1 LTBP2 MUC3A LRP1B LDLR FBN3 NOTCH2 LRP8 | 1.27e-32 | 265 | 53 | 25 | PS01186 |
| Domain | EGF_CA | SNED1 VLDLR SCUBE1 STAB2 FBN1 SCUBE2 SUSD1 DLL4 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 LRP1B LDLR FBN3 NOTCH2 LRP8 | 6.79e-27 | 122 | 53 | 18 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | SNED1 VLDLR SCUBE1 STAB2 FBN1 SCUBE2 SUSD1 DLL4 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 LRP1B LDLR FBN3 NOTCH2 LRP8 | 9.27e-27 | 124 | 53 | 18 | IPR001881 |
| Domain | Growth_fac_rcpt_ | VLDLR SCUBE1 STAB2 FBN1 SCUBE2 CRIM1 TIE1 SUSD1 DLL4 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 LRP1B LDLR FBN3 NOTCH2 LRP8 | 9.88e-27 | 156 | 53 | 19 | IPR009030 |
| Domain | ASX_HYDROXYL | SNED1 VLDLR SCUBE1 FBN1 SCUBE2 SUSD1 DLL4 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 LRP1B LDLR FBN3 NOTCH2 LRP8 | 1.62e-26 | 100 | 53 | 17 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | SNED1 VLDLR SCUBE1 FBN1 SCUBE2 SUSD1 DLL4 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 LRP1B LDLR FBN3 NOTCH2 LRP8 | 4.69e-26 | 106 | 53 | 17 | IPR000152 |
| Domain | EGF_Ca-bd_CS | SNED1 VLDLR SCUBE1 FBN1 SCUBE2 SUSD1 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 LRP1B LDLR FBN3 NOTCH2 LRP8 | 9.72e-25 | 97 | 53 | 16 | IPR018097 |
| Domain | EGF_CA | SNED1 VLDLR SCUBE1 FBN1 SCUBE2 SUSD1 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 LRP1B LDLR FBN3 NOTCH2 LRP8 | 1.38e-24 | 99 | 53 | 16 | PS01187 |
| Domain | EGF_CA | VLDLR SCUBE1 FBN1 SCUBE2 SUSD1 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 LRP1B LDLR FBN3 NOTCH2 LRP8 | 1.33e-23 | 86 | 53 | 15 | PF07645 |
| Domain | EGF | SNED1 VLDLR STAB2 SCUBE2 TIE1 DLL4 JAG1 SCUBE3 LRP4 LTBP1 LTBP2 TECTA LRP1B FBN3 NOTCH2 LRP8 | 8.28e-23 | 126 | 53 | 16 | PF00008 |
| Domain | EGF_extracell | 9.32e-16 | 60 | 53 | 10 | IPR013111 | |
| Domain | EGF_2 | 9.32e-16 | 60 | 53 | 10 | PF07974 | |
| Domain | cEGF | 3.63e-15 | 26 | 53 | 8 | IPR026823 | |
| Domain | cEGF | 3.63e-15 | 26 | 53 | 8 | PF12662 | |
| Domain | VWC_out | 1.03e-11 | 19 | 53 | 6 | SM00215 | |
| Domain | Ldl_recept_b | 2.98e-10 | 14 | 53 | 5 | PF00058 | |
| Domain | LDLRB | 2.98e-10 | 14 | 53 | 5 | PS51120 | |
| Domain | LY | 4.46e-10 | 15 | 53 | 5 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.46e-10 | 15 | 53 | 5 | IPR000033 | |
| Domain | VWC | 1.00e-09 | 38 | 53 | 6 | SM00214 | |
| Domain | VWF_dom | 1.89e-09 | 42 | 53 | 6 | IPR001007 | |
| Domain | TB | 2.01e-09 | 7 | 53 | 4 | PF00683 | |
| Domain | - | 4.01e-09 | 8 | 53 | 4 | 3.90.290.10 | |
| Domain | TB | 7.20e-09 | 9 | 53 | 4 | PS51364 | |
| Domain | TB_dom | 7.20e-09 | 9 | 53 | 4 | IPR017878 | |
| Domain | EGF_3 | 2.81e-08 | 12 | 53 | 4 | PF12947 | |
| Domain | TIL | 2.81e-08 | 12 | 53 | 4 | PF01826 | |
| Domain | EGF_dom | 2.81e-08 | 12 | 53 | 4 | IPR024731 | |
| Domain | C8 | 2.81e-08 | 12 | 53 | 4 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 4.05e-08 | 13 | 53 | 4 | IPR014853 | |
| Domain | C8 | 4.05e-08 | 13 | 53 | 4 | SM00832 | |
| Domain | TIL_dom | 5.66e-08 | 14 | 53 | 4 | IPR002919 | |
| Domain | - | 8.12e-08 | 39 | 53 | 5 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 9.25e-08 | 40 | 53 | 5 | IPR023415 | |
| Domain | VWD | 1.03e-07 | 16 | 53 | 4 | SM00216 | |
| Domain | VWF_type-D | 1.03e-07 | 16 | 53 | 4 | IPR001846 | |
| Domain | VWFD | 1.03e-07 | 16 | 53 | 4 | PS51233 | |
| Domain | VWD | 1.03e-07 | 16 | 53 | 4 | PF00094 | |
| Domain | Ldl_recept_a | 1.70e-07 | 45 | 53 | 5 | PF00057 | |
| Domain | - | 1.90e-07 | 46 | 53 | 5 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.90e-07 | 46 | 53 | 5 | IPR011042 | |
| Domain | LDLRA_1 | 2.37e-07 | 48 | 53 | 5 | PS01209 | |
| Domain | LDLRA_2 | 2.63e-07 | 49 | 53 | 5 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 2.63e-07 | 49 | 53 | 5 | IPR002172 | |
| Domain | LDLa | 2.63e-07 | 49 | 53 | 5 | SM00192 | |
| Domain | hEGF | 1.12e-06 | 28 | 53 | 4 | PF12661 | |
| Domain | Ephrin_rec_like | 3.50e-06 | 11 | 53 | 3 | PF07699 | |
| Domain | VWFC_2 | 3.97e-06 | 38 | 53 | 4 | PS50184 | |
| Domain | TILa | 2.37e-05 | 3 | 53 | 2 | PF12714 | |
| Domain | TILa_dom | 2.37e-05 | 3 | 53 | 2 | IPR025615 | |
| Domain | FBN | 2.37e-05 | 3 | 53 | 2 | IPR011398 | |
| Domain | DSL | 4.72e-05 | 4 | 53 | 2 | PF01414 | |
| Domain | DSL | 4.72e-05 | 4 | 53 | 2 | SM00051 | |
| Domain | Ephrin_rec_like | 4.75e-05 | 25 | 53 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 4.75e-05 | 25 | 53 | 3 | IPR011641 | |
| Domain | ACR | 6.01e-05 | 27 | 53 | 3 | SM00608 | |
| Domain | ADAM_Cys-rich | 6.01e-05 | 27 | 53 | 3 | IPR006586 | |
| Domain | NIDO_dom | 7.86e-05 | 5 | 53 | 2 | IPR003886 | |
| Domain | DSL | 7.86e-05 | 5 | 53 | 2 | IPR001774 | |
| Domain | NIDO | 7.86e-05 | 5 | 53 | 2 | SM00539 | |
| Domain | NIDO | 7.86e-05 | 5 | 53 | 2 | PF06119 | |
| Domain | DSL | 7.86e-05 | 5 | 53 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 7.86e-05 | 5 | 53 | 2 | IPR011651 | |
| Domain | NIDO | 7.86e-05 | 5 | 53 | 2 | PS51220 | |
| Domain | MNNL | 7.86e-05 | 5 | 53 | 2 | PF07657 | |
| Domain | Peptidase_M12B_N | 1.83e-04 | 39 | 53 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.83e-04 | 39 | 53 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.98e-04 | 40 | 53 | 3 | PS00427 | |
| Domain | Reprolysin | 1.98e-04 | 40 | 53 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 1.98e-04 | 40 | 53 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.98e-04 | 40 | 53 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 1.98e-04 | 40 | 53 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 2.13e-04 | 41 | 53 | 3 | IPR001762 | |
| Domain | CUB | 3.62e-04 | 49 | 53 | 3 | PF00431 | |
| Domain | CUB | 3.85e-04 | 50 | 53 | 3 | SM00042 | |
| Domain | Fol_N | 4.27e-04 | 11 | 53 | 2 | IPR003645 | |
| Domain | - | 4.27e-04 | 11 | 53 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 4.27e-04 | 11 | 53 | 2 | IPR023413 | |
| Domain | FOLN | 4.27e-04 | 11 | 53 | 2 | SM00274 | |
| Domain | - | 4.32e-04 | 52 | 53 | 3 | 2.60.120.290 | |
| Domain | CUB | 4.57e-04 | 53 | 53 | 3 | PS01180 | |
| Domain | CUB_dom | 5.67e-04 | 57 | 53 | 3 | IPR000859 | |
| Domain | SEA | 7.03e-04 | 14 | 53 | 2 | SM00200 | |
| Domain | CTCK_1 | 1.17e-03 | 18 | 53 | 2 | PS01185 | |
| Domain | ADAM_CR | 1.17e-03 | 18 | 53 | 2 | PF08516 | |
| Domain | Wnt | 1.31e-03 | 19 | 53 | 2 | IPR005817 | |
| Domain | Wnt_CS | 1.31e-03 | 19 | 53 | 2 | IPR018161 | |
| Domain | wnt | 1.31e-03 | 19 | 53 | 2 | PF00110 | |
| Domain | WNT1 | 1.31e-03 | 19 | 53 | 2 | SM00097 | |
| Domain | WNT1 | 1.31e-03 | 19 | 53 | 2 | PS00246 | |
| Domain | - | 1.45e-03 | 20 | 53 | 2 | 4.10.70.10 | |
| Domain | MetalloPept_cat_dom | 1.57e-03 | 81 | 53 | 3 | IPR024079 | |
| Domain | - | 1.57e-03 | 81 | 53 | 3 | 3.40.390.10 | |
| Domain | Disintegrin | 1.60e-03 | 21 | 53 | 2 | PF00200 | |
| Domain | DISIN | 1.60e-03 | 21 | 53 | 2 | SM00050 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | SCUBE1 FBN1 VWF COL19A1 ADAM9 SCUBE3 LRP4 LTBP1 LTBP2 ITGB1 FBN3 | 2.32e-09 | 300 | 46 | 11 | M610 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.19e-07 | 37 | 46 | 5 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.92e-07 | 44 | 46 | 5 | M26969 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 1.09e-06 | 57 | 46 | 5 | M48326 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 1.13e-06 | 7 | 46 | 3 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 1.13e-06 | 7 | 46 | 3 | M22049 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.19e-06 | 25 | 46 | 4 | M39713 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.61e-06 | 258 | 46 | 8 | MM14572 | |
| Pathway | PID_REELIN_PATHWAY | 1.92e-06 | 28 | 46 | 4 | M69 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.34e-06 | 32 | 46 | 4 | MM14854 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.82e-06 | 140 | 46 | 6 | M587 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.75e-06 | 38 | 46 | 4 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.51e-06 | 39 | 46 | 4 | MM14601 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 9.09e-06 | 13 | 46 | 3 | M47423 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.60e-05 | 47 | 46 | 4 | M646 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.93e-05 | 118 | 46 | 5 | M39852 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 4.52e-05 | 61 | 46 | 4 | M39540 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 4.79e-05 | 22 | 46 | 3 | M27210 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 9.00e-05 | 27 | 46 | 3 | M39545 | |
| Pathway | PID_LIS1_PATHWAY | 1.01e-04 | 28 | 46 | 3 | M163 | |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 1.04e-04 | 5 | 46 | 2 | M27759 | |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 1.04e-04 | 5 | 46 | 2 | MM15504 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.13e-04 | 77 | 46 | 4 | MM14670 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.44e-04 | 82 | 46 | 4 | MM15922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.66e-04 | 33 | 46 | 3 | M604 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.71e-04 | 161 | 46 | 5 | M39770 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 2.16e-04 | 7 | 46 | 2 | M27199 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.44e-04 | 94 | 46 | 4 | M1041 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 2.88e-04 | 8 | 46 | 2 | M47850 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 3.70e-04 | 9 | 46 | 2 | M47866 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 4.19e-04 | 45 | 46 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 4.47e-04 | 46 | 46 | 3 | MM15971 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 4.54e-04 | 431 | 46 | 7 | M39729 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.77e-04 | 47 | 46 | 3 | M7946 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.09e-04 | 114 | 46 | 4 | MM14571 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 5.62e-04 | 11 | 46 | 2 | M27882 | |
| Pathway | WP_PAFAH1B1_COPY_NUMBER_VARIATION | 5.62e-04 | 11 | 46 | 2 | M48106 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 5.80e-04 | 118 | 46 | 4 | MM15588 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 6.73e-04 | 12 | 46 | 2 | M47532 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 7.94e-04 | 13 | 46 | 2 | M42551 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 9.25e-04 | 14 | 46 | 2 | MM1531 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 9.30e-04 | 59 | 46 | 3 | M39886 | |
| Pathway | PID_NOTCH_PATHWAY | 9.30e-04 | 59 | 46 | 3 | M17 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 1.06e-03 | 15 | 46 | 2 | M47663 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.06e-03 | 15 | 46 | 2 | M27202 | |
| Pathway | WP_CANCER_PATHWAYS | 1.18e-03 | 507 | 46 | 7 | M48302 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.21e-03 | 16 | 46 | 2 | M47424 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.21e-03 | 16 | 46 | 2 | M9450 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.37e-03 | 17 | 46 | 2 | M39389 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.40e-03 | 68 | 46 | 3 | M27303 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.40e-03 | 68 | 46 | 3 | M39456 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.41e-03 | 381 | 46 | 6 | M48063 | |
| Pathway | WP_NEPHROGENESIS | 1.54e-03 | 18 | 46 | 2 | M40045 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 1.72e-03 | 19 | 46 | 2 | M47836 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.72e-03 | 19 | 46 | 2 | MM15594 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 1.72e-03 | 19 | 46 | 2 | M22005 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.84e-03 | 161 | 46 | 4 | M27871 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.94e-03 | 76 | 46 | 3 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 2.40e-03 | 82 | 46 | 3 | M594 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.58e-03 | 84 | 46 | 3 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.66e-03 | 85 | 46 | 3 | M16441 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 2.98e-03 | 25 | 46 | 2 | MM14940 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.98e-03 | 25 | 46 | 2 | M27879 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 3.22e-03 | 26 | 46 | 2 | M27239 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 3.47e-03 | 27 | 46 | 2 | M287 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 3.73e-03 | 28 | 46 | 2 | M47835 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 3.73e-03 | 28 | 46 | 2 | MM1391 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 3.87e-03 | 97 | 46 | 3 | MM15926 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 4.00e-03 | 29 | 46 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 4.00e-03 | 29 | 46 | 2 | M47377 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 4.33e-03 | 101 | 46 | 3 | M39448 | |
| Pubmed | 5.19e-12 | 4 | 54 | 4 | 10571240 | ||
| Pubmed | PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide. | 2.59e-11 | 5 | 54 | 4 | 18675252 | |
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 7.76e-11 | 6 | 54 | 4 | 18957219 | |
| Pubmed | Reelin binds alpha3beta1 integrin and inhibits neuronal migration. | 7.76e-11 | 6 | 54 | 4 | 10939329 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.49e-10 | 21 | 54 | 5 | 21337463 | |
| Pubmed | 3.62e-10 | 8 | 54 | 4 | 10380922 | ||
| Pubmed | Reelin together with ApoER2 regulates interneuron migration in the olfactory bulb. | 3.54e-09 | 3 | 54 | 3 | 23209795 | |
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 3.54e-09 | 3 | 54 | 3 | 12270931 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 18778775 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 28123028 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 11920707 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 19948739 | ||
| Pubmed | Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. | 3.54e-09 | 3 | 54 | 3 | 12670700 | |
| Pubmed | Functional importance of covalent homodimer of reelin protein linked via its central region. | 3.54e-09 | 3 | 54 | 3 | 21844191 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 31991528 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 23083738 | ||
| Pubmed | Contributions of VLDLR and LRP8 in the establishment of retinogeniculate projections. | 3.54e-09 | 3 | 54 | 3 | 23758727 | |
| Pubmed | ApoER2 function in the establishment and maintenance of retinal synaptic connectivity. | 3.54e-09 | 3 | 54 | 3 | 21976526 | |
| Pubmed | Reelin and its receptors, VLDLR and ApoER2, in melanocytic nevi. | 3.54e-09 | 3 | 54 | 3 | 28255385 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 17293099 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.19e-08 | 101 | 54 | 6 | 23382219 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 16481437 | ||
| Pubmed | Disabled1 regulates the intracellular trafficking of reelin receptors. | 1.41e-08 | 4 | 54 | 3 | 15718228 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 14724251 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 17548821 | ||
| Pubmed | Structural basis for specific recognition of reelin by its receptors. | 1.41e-08 | 4 | 54 | 3 | 20223215 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 17442808 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 10571241 | ||
| Pubmed | Expression and regulation of reelin and its receptors in the enteric nervous system. | 1.41e-08 | 4 | 54 | 3 | 24844606 | |
| Pubmed | Reelin receptors in developing laminated brain structures of mouse and human. | 1.41e-08 | 4 | 54 | 3 | 15548227 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 22109552 | ||
| Pubmed | Differential binding of ligands to the apolipoprotein E receptor 2. | 1.41e-08 | 4 | 54 | 3 | 12899622 | |
| Pubmed | Components of the reelin signaling pathway are expressed in the spinal cord. | 1.41e-08 | 4 | 54 | 3 | 14750162 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 21039973 | ||
| Pubmed | Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. | 1.41e-08 | 4 | 54 | 3 | 12167620 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 24381170 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 12687696 | ||
| Pubmed | Reelin provides an inhibitory signal in the migration of gonadotropin-releasing hormone neurons. | 1.41e-08 | 4 | 54 | 3 | 16207762 | |
| Pubmed | Contribution of the Reelin signaling pathways to nociceptive processing. | 1.41e-08 | 4 | 54 | 3 | 18279306 | |
| Pubmed | Interaction of reelin signaling and Lis1 in brain development. | 3.53e-08 | 5 | 54 | 3 | 14578885 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 17494763 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 23383134 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 14985430 | ||
| Pubmed | A Unique "Reversed" Migration of Neurons in the Developing Claustrum. | 3.53e-08 | 5 | 54 | 3 | 36631266 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 19167437 | ||
| Pubmed | Mice with Dab1 or Vldlr insufficiency exhibit abnormal neonatal vocalization patterns. | 3.53e-08 | 5 | 54 | 3 | 27184477 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 22419519 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 35064244 | ||
| Pubmed | PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain. | 7.05e-08 | 6 | 54 | 3 | 20453200 | |
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 21048135 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 28484035 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 10557205 | ||
| Pubmed | Reelin controls the positioning of brainstem serotonergic raphe neurons. | 7.05e-08 | 6 | 54 | 3 | 30001399 | |
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 12586425 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 23976984 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 19217325 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 25308109 | ||
| Pubmed | The Pafah1b complex interacts with the reelin receptor VLDLR. | 1.23e-07 | 7 | 54 | 3 | 17330141 | |
| Pubmed | 1.23e-07 | 7 | 54 | 3 | 15249135 | ||
| Pubmed | 1.23e-07 | 7 | 54 | 3 | 25639508 | ||
| Pubmed | 1.23e-07 | 7 | 54 | 3 | 19710317 | ||
| Pubmed | 1.23e-07 | 7 | 54 | 3 | 12169628 | ||
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 12526740 | ||
| Pubmed | Rescue of ataxia and preplate splitting by ectopic expression of Reelin in reeler mice. | 1.97e-07 | 8 | 54 | 3 | 11856531 | |
| Pubmed | 2.95e-07 | 9 | 54 | 3 | 12122015 | ||
| Pubmed | 2.95e-07 | 9 | 54 | 3 | 16245338 | ||
| Pubmed | Disruption of reelin signaling alters mammary gland morphogenesis. | 2.95e-07 | 9 | 54 | 3 | 21266412 | |
| Pubmed | 2.95e-07 | 9 | 54 | 3 | 19129405 | ||
| Pubmed | 2.95e-07 | 9 | 54 | 3 | 20005821 | ||
| Pubmed | 4.21e-07 | 10 | 54 | 3 | 29127326 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 4.21e-07 | 10 | 54 | 3 | 23665443 | |
| Pubmed | 4.21e-07 | 10 | 54 | 3 | 30127721 | ||
| Pubmed | 4.21e-07 | 10 | 54 | 3 | 24015274 | ||
| Pubmed | 4.21e-07 | 10 | 54 | 3 | 20809939 | ||
| Pubmed | VLDLR RELN FBN1 VWF CRIM1 ADAM23 ADAM9 LRP4 ASTN1 HERC2 LRP1B STAT3 | 5.01e-07 | 1285 | 54 | 12 | 35914814 | |
| Pubmed | Localization of reelin signaling pathway components in murine midbrain and striatum. | 5.79e-07 | 11 | 54 | 3 | 25418135 | |
| Pubmed | Reelin signaling is necessary for a specific step in the migration of hindbrain efferent neurons. | 5.79e-07 | 11 | 54 | 3 | 15703280 | |
| Pubmed | 7.71e-07 | 12 | 54 | 3 | 15465494 | ||
| Pubmed | Uncontrolled angiogenic precursor expansion causes coronary artery anomalies in mice lacking Pofut1. | 9.60e-07 | 48 | 54 | 4 | 28924218 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.00e-06 | 13 | 54 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 1.00e-06 | 13 | 54 | 3 | 20558824 | |
| Pubmed | Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration. | 1.27e-06 | 14 | 54 | 3 | 21460838 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 1.27e-06 | 14 | 54 | 3 | 17389516 | |
| Pubmed | 1.27e-06 | 14 | 54 | 3 | 14757642 | ||
| Pubmed | 1.59e-06 | 15 | 54 | 3 | 24449842 | ||
| Pubmed | 1.59e-06 | 15 | 54 | 3 | 12971992 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FBN1 CRIM1 ADAM9 LRP4 LTBP1 LTBP2 ITGB1 LRP1B LDLR NOTCH2 LRP8 | 1.95e-06 | 1201 | 54 | 11 | 35696571 |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.95e-06 | 16 | 54 | 3 | 12617809 | |
| Pubmed | 1.95e-06 | 16 | 54 | 3 | 17273555 | ||
| Pubmed | 1.95e-06 | 16 | 54 | 3 | 19068216 | ||
| Pubmed | 2.22e-06 | 59 | 54 | 4 | 21421844 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 29442527 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 25858550 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 12363388 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 19393635 | ||
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 2.37e-06 | 2 | 54 | 2 | 28669633 | |
| Pubmed | The expression profile of Jagged1 and Delta-like 4 in hepatocellular carcinoma. | 2.37e-06 | 2 | 54 | 2 | 30660174 | |
| Pubmed | Clinical features, outcomes, and genetic analysis in Korean children with Alagille syndrome. | 2.37e-06 | 2 | 54 | 2 | 25676721 | |
| Pubmed | Renal involvement and the role of Notch signalling in Alagille syndrome. | 2.37e-06 | 2 | 54 | 2 | 23752887 | |
| Pubmed | The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. | 2.37e-06 | 2 | 54 | 2 | 17261317 | |
| Interaction | NTN5 interactions | 2.84e-11 | 24 | 52 | 6 | int:NTN5 | |
| Interaction | ZNF408 interactions | 3.41e-09 | 145 | 52 | 8 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 7.19e-09 | 57 | 52 | 6 | int:ZFP41 | |
| Interaction | IGFL3 interactions | 3.85e-08 | 75 | 52 | 6 | int:IGFL3 | |
| Interaction | FBXO2 interactions | 8.22e-08 | 411 | 52 | 10 | int:FBXO2 | |
| Interaction | SCUBE1 interactions | 1.61e-07 | 5 | 52 | 3 | int:SCUBE1 | |
| Interaction | RELN interactions | 6.62e-07 | 27 | 52 | 4 | int:RELN | |
| Interaction | FBN2 interactions | 6.90e-07 | 65 | 52 | 5 | int:FBN2 | |
| Interaction | ST14 interactions | 9.85e-07 | 207 | 52 | 7 | int:ST14 | |
| Interaction | ZNF778 interactions | 2.63e-06 | 11 | 52 | 3 | int:ZNF778 | |
| Interaction | VLDLR interactions | 3.03e-06 | 39 | 52 | 4 | int:VLDLR | |
| Interaction | IGSF5 interactions | 5.78e-06 | 14 | 52 | 3 | int:IGSF5 | |
| Interaction | DEFB123 interactions | 8.86e-06 | 16 | 52 | 3 | int:DEFB123 | |
| Interaction | MFAP5 interactions | 9.73e-06 | 52 | 52 | 4 | int:MFAP5 | |
| Interaction | DYRK1A interactions | 1.05e-05 | 552 | 52 | 9 | int:DYRK1A | |
| Interaction | SCUBE2 interactions | 3.91e-05 | 4 | 52 | 2 | int:SCUBE2 | |
| Interaction | FEZF1 interactions | 5.07e-05 | 28 | 52 | 3 | int:FEZF1 | |
| Interaction | SNX17 interactions | 5.66e-05 | 81 | 52 | 4 | int:SNX17 | |
| Interaction | LRP8 interactions | 7.16e-05 | 86 | 52 | 4 | int:LRP8 | |
| Interaction | EPPIN interactions | 9.73e-05 | 6 | 52 | 2 | int:EPPIN | |
| Interaction | LRPAP1 interactions | 9.95e-05 | 180 | 52 | 5 | int:LRPAP1 | |
| Interaction | DLK2 interactions | 1.09e-04 | 36 | 52 | 3 | int:DLK2 | |
| Interaction | EDDM3A interactions | 1.18e-04 | 37 | 52 | 3 | int:EDDM3A | |
| Interaction | ZNF594 interactions | 1.36e-04 | 7 | 52 | 2 | int:ZNF594 | |
| Interaction | CD36 interactions | 1.39e-04 | 39 | 52 | 3 | int:CD36 | |
| Interaction | DAB1 interactions | 1.67e-04 | 107 | 52 | 4 | int:DAB1 | |
| Interaction | SCUBE3 interactions | 1.81e-04 | 8 | 52 | 2 | int:SCUBE3 | |
| Interaction | ZNF398 interactions | 1.86e-04 | 43 | 52 | 3 | int:ZNF398 | |
| Interaction | ZNF480 interactions | 2.32e-04 | 9 | 52 | 2 | int:ZNF480 | |
| Interaction | SLC25A36 interactions | 2.32e-04 | 9 | 52 | 2 | int:SLC25A36 | |
| Interaction | ZKSCAN2 interactions | 2.32e-04 | 9 | 52 | 2 | int:ZKSCAN2 | |
| Interaction | PATE1 interactions | 2.75e-04 | 49 | 52 | 3 | int:PATE1 | |
| Interaction | FOXD4L6 interactions | 2.75e-04 | 49 | 52 | 3 | int:FOXD4L6 | |
| Interaction | ZNF766 interactions | 2.90e-04 | 10 | 52 | 2 | int:ZNF766 | |
| Interaction | ZSCAN21 interactions | 3.32e-04 | 128 | 52 | 4 | int:ZSCAN21 | |
| Interaction | FBLN1 interactions | 3.42e-04 | 129 | 52 | 4 | int:FBLN1 | |
| Interaction | NPNT interactions | 3.54e-04 | 11 | 52 | 2 | int:NPNT | |
| Interaction | NDUFAF6 interactions | 3.54e-04 | 11 | 52 | 2 | int:NDUFAF6 | |
| Interaction | VCAN interactions | 3.66e-04 | 54 | 52 | 3 | int:VCAN | |
| Interaction | EFNB3 interactions | 3.87e-04 | 55 | 52 | 3 | int:EFNB3 | |
| Interaction | MYLIP interactions | 4.08e-04 | 56 | 52 | 3 | int:MYLIP | |
| Interaction | ZNF555 interactions | 4.24e-04 | 12 | 52 | 2 | int:ZNF555 | |
| Interaction | ZNF563 interactions | 4.24e-04 | 12 | 52 | 2 | int:ZNF563 | |
| Interaction | MFAP2 interactions | 4.24e-04 | 12 | 52 | 2 | int:MFAP2 | |
| Interaction | ZNF611 interactions | 4.24e-04 | 12 | 52 | 2 | int:ZNF611 | |
| Interaction | ANKRD36B interactions | 5.00e-04 | 60 | 52 | 3 | int:ANKRD36B | |
| Interaction | ZNF709 interactions | 5.00e-04 | 13 | 52 | 2 | int:ZNF709 | |
| Interaction | PHKB interactions | 5.77e-04 | 63 | 52 | 3 | int:PHKB | |
| Interaction | RNASE4 interactions | 5.83e-04 | 14 | 52 | 2 | int:RNASE4 | |
| Interaction | RAB25 interactions | 5.94e-04 | 265 | 52 | 5 | int:RAB25 | |
| Interaction | ITGA3 interactions | 7.21e-04 | 68 | 52 | 3 | int:ITGA3 | |
| Interaction | TIMP2 interactions | 7.25e-04 | 277 | 52 | 5 | int:TIMP2 | |
| Interaction | ZNF260 interactions | 7.66e-04 | 16 | 52 | 2 | int:ZNF260 | |
| Interaction | ZNF628 interactions | 7.66e-04 | 16 | 52 | 2 | int:ZNF628 | |
| Interaction | LGALS3BP interactions | 8.37e-04 | 286 | 52 | 5 | int:LGALS3BP | |
| Interaction | ADAM2 interactions | 8.66e-04 | 17 | 52 | 2 | int:ADAM2 | |
| Interaction | NEURL1 interactions | 8.66e-04 | 17 | 52 | 2 | int:NEURL1 | |
| Interaction | ZNF708 interactions | 9.73e-04 | 18 | 52 | 2 | int:ZNF708 | |
| Cytoband | 7q22 | 1.26e-05 | 38 | 54 | 3 | 7q22 | |
| GeneFamily | Low density lipoprotein receptors | 5.20e-11 | 13 | 40 | 5 | 634 | |
| GeneFamily | CD molecules|Mucins | 1.30e-05 | 21 | 40 | 3 | 648 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 2.86e-05 | 4 | 40 | 2 | 628 | |
| GeneFamily | Wnt family|Endogenous ligands | 7.97e-04 | 19 | 40 | 2 | 360 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.62e-03 | 27 | 40 | 2 | 47 | |
| GeneFamily | Fibronectin type III domain containing | 5.29e-03 | 160 | 40 | 3 | 555 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 7.05e-03 | 57 | 40 | 2 | 1179 | |
| GeneFamily | PHD finger proteins | 1.69e-02 | 90 | 40 | 2 | 88 | |
| Coexpression | NABA_MATRISOME | SNED1 ADAMTS19 RELN SCUBE1 FBN1 VWF SCUBE2 COL19A1 CRIM1 ADAM23 ADAM9 WNT7A WNT8B MUC19 SCUBE3 LTBP1 LTBP2 TECTA MUC3A IL17F FBN3 | 2.21e-16 | 1026 | 53 | 21 | M5889 |
| Coexpression | NABA_MATRISOME | SNED1 ADAMTS19 RELN SCUBE1 FBN1 VWF SCUBE2 COL19A1 CRIM1 ADAM23 ADAM9 WNT7A WNT8B MUC19 SCUBE3 LTBP1 LTBP2 TECTA IL17F EGFEM1P | 2.53e-15 | 1008 | 53 | 20 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | 1.50e-10 | 270 | 53 | 10 | MM17057 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.61e-10 | 191 | 53 | 9 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 1.80e-10 | 275 | 53 | 10 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.03e-10 | 196 | 53 | 9 | M3008 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS19 SCUBE1 SCUBE2 ADAM23 ADAM9 WNT7A WNT8B MUC19 SCUBE3 MUC3A IL17F | 2.53e-07 | 751 | 53 | 11 | M5885 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SNED1 ADAMTS19 RELN SCUBE1 SCUBE2 COL19A1 DLL4 WNT7A JAG1 SCUBE3 SHISA2 GALNT6 | 1.19e-06 | 1074 | 53 | 12 | M1941 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS19 SCUBE1 SCUBE2 ADAM23 ADAM9 WNT7A WNT8B MUC19 SCUBE3 IL17F | 1.92e-06 | 738 | 53 | 10 | MM17058 |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 2.86e-06 | 309 | 53 | 7 | M1973 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 4.29e-06 | 16 | 53 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 4.29e-06 | 16 | 53 | 3 | M2207 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | 9.85e-06 | 888 | 53 | 10 | M39049 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.20e-05 | 385 | 53 | 7 | M39264 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 1.29e-05 | 721 | 53 | 9 | M1999 | |
| Coexpression | JONES_OVARY_ENDOTHELIAL | 1.91e-05 | 162 | 53 | 5 | M48350 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 1.97e-05 | 163 | 53 | 5 | M12112 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 2.84e-05 | 295 | 53 | 6 | M39121 | |
| Coexpression | JONES_OVARY_NK_CELL | 3.20e-05 | 89 | 53 | 4 | M48353 | |
| Coexpression | BENPORATH_EED_TARGETS | RELN COL19A1 DLL4 WNT7A STK32B SCUBE3 ASTN1 SHISA2 LTBP2 PDZD2 | 4.45e-05 | 1059 | 53 | 10 | M7617 |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 4.88e-05 | 35 | 53 | 3 | M11788 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 5.24e-05 | 200 | 53 | 5 | M5915 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN | 5.24e-05 | 200 | 53 | 5 | M4354 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 5.32e-05 | 36 | 53 | 3 | MM1212 | |
| Coexpression | NABA_SECRETED_FACTORS | 6.06e-05 | 338 | 53 | 6 | MM17064 | |
| Coexpression | NABA_SECRETED_FACTORS | 6.57e-05 | 343 | 53 | 6 | M5883 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 7.88e-05 | 41 | 53 | 3 | M47988 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 9.25e-05 | 365 | 53 | 6 | M39018 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 1.11e-04 | 8 | 53 | 2 | M9884 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 1.12e-04 | 235 | 53 | 5 | M5311 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_LB_UP | 1.19e-04 | 47 | 53 | 3 | M14744 | |
| Coexpression | JONES_OVARY_MAST_CELL | 1.19e-04 | 47 | 53 | 3 | M48356 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.43e-04 | 50 | 53 | 3 | M1259 | |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 1.44e-04 | 131 | 53 | 4 | M40316 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 1.50e-04 | 574 | 53 | 7 | M39056 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.61e-04 | 52 | 53 | 3 | MM1118 | |
| Coexpression | GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN | 1.62e-04 | 135 | 53 | 4 | M6344 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.62e-04 | 135 | 53 | 4 | M5825 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 1.80e-04 | 54 | 53 | 3 | M5312 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 1.83e-04 | 795 | 53 | 8 | M39050 | |
| Coexpression | LU_AGING_BRAIN_UP | 1.90e-04 | 263 | 53 | 5 | M5547 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.07e-04 | 268 | 53 | 5 | M45796 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 2.08e-04 | 144 | 53 | 4 | M5942 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 2.09e-04 | 1035 | 53 | 9 | M9898 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 2.11e-04 | 57 | 53 | 3 | MM463 | |
| Coexpression | SASAKI_TARGETS_OF_TP73_AND_TP63 | 2.61e-04 | 12 | 53 | 2 | M17374 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | 2.68e-04 | 154 | 53 | 4 | M6824 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 3.62e-04 | 1115 | 53 | 9 | M10371 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 3.70e-04 | 304 | 53 | 5 | M39113 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 3.99e-04 | 171 | 53 | 4 | M8820 | |
| Coexpression | JONES_OVARY_PERICYTE | 4.08e-04 | 172 | 53 | 4 | M48351 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 4.74e-04 | 179 | 53 | 4 | M39308 | |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL | 5.15e-04 | 327 | 53 | 5 | M4008 | |
| Coexpression | MOREIRA_RESPONSE_TO_TSA_DN | 6.01e-04 | 18 | 53 | 2 | M3506 | |
| Coexpression | GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN | 6.54e-04 | 195 | 53 | 4 | M9706 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 6.63e-04 | 84 | 53 | 3 | M15484 | |
| Coexpression | MTOR_UP.N4.V1_UP | 6.67e-04 | 196 | 53 | 4 | M2757 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | 6.67e-04 | 196 | 53 | 4 | M9867 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C1 | 6.71e-04 | 19 | 53 | 2 | M16026 | |
| Coexpression | HEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS | 6.71e-04 | 19 | 53 | 2 | MM420 | |
| Coexpression | GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN | 6.80e-04 | 197 | 53 | 4 | M7696 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 6.80e-04 | 197 | 53 | 4 | M4421 | |
| Coexpression | GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN | 7.19e-04 | 200 | 53 | 4 | M5099 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_UP | 7.19e-04 | 200 | 53 | 4 | M6426 | |
| Coexpression | GSE27786_NKTCELL_VS_NEUTROPHIL_DN | 7.19e-04 | 200 | 53 | 4 | M4869 | |
| Coexpression | GSE2826_WT_VS_XID_BCELL_DN | 7.19e-04 | 200 | 53 | 4 | M4897 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 7.19e-04 | 200 | 53 | 4 | M6620 | |
| Coexpression | GSE17721_CTRL_VS_CPG_4H_BMDC_DN | 7.19e-04 | 200 | 53 | 4 | M3763 | |
| Coexpression | GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP | 7.19e-04 | 200 | 53 | 4 | M6790 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN | 7.19e-04 | 200 | 53 | 4 | M3893 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | RELN STAB2 FBN1 CRIM1 TIE1 APOLD1 DLL4 JAG1 ASTN1 LTBP1 LTBP2 | 9.09e-09 | 439 | 53 | 11 | GSM777059_500 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.43e-07 | 450 | 53 | 10 | GSM777063_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 4.32e-07 | 189 | 53 | 7 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | SCUBE1 FBN1 SCUBE2 ADSS2 ADAM23 JAG1 WNT8B SCUBE3 LRP4 ASTN1 LTBP2 NOTCH2 STAT3 | 5.16e-07 | 967 | 53 | 13 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 5.89e-07 | 65 | 53 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 3.53e-06 | 166 | 53 | 6 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 6.02e-06 | 398 | 53 | 8 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.02e-05 | 428 | 53 | 8 | JC_hmvEC_1000_K4 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | SCUBE1 FBN1 SCUBE2 ADAM23 ADAM9 JAG1 WNT8B SCUBE3 LRP4 ASTN1 LTBP2 NOTCH2 | 1.04e-05 | 1075 | 53 | 12 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | VLDLR RELN FBN1 CRIM1 ADAM23 ADAM9 JAG1 SCUBE3 LTBP1 ITGB1 NOTCH2 | 1.17e-05 | 905 | 53 | 11 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 2.03e-05 | 783 | 53 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | ADAMTS19 RELN SCUBE1 SCUBE2 WNT8B MUC19 SCUBE3 ASTN1 SHISA2 MUC3A FBN3 | 2.36e-05 | 976 | 53 | 11 | PCBC_ECTO_blastocyst_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 2.59e-05 | 487 | 53 | 8 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_500 | 2.91e-05 | 495 | 53 | 8 | PCBC_ECTO_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 2.99e-05 | 497 | 53 | 8 | PCBC_ECTO_fibroblast_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 3.37e-05 | 148 | 53 | 5 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 3.56e-05 | 370 | 53 | 7 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | SCUBE1 FBN1 SCUBE2 ADAM9 JAG1 WNT8B SCUBE3 ASTN1 SHISA2 LTBP1 LTBP2 FBN3 NOTCH2 | 4.77e-05 | 1466 | 53 | 13 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 6.03e-05 | 85 | 53 | 4 | GSM399454_100 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | 6.31e-05 | 86 | 53 | 4 | GSM399442_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 7.48e-05 | 175 | 53 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 7.87e-05 | 91 | 53 | 4 | GSM777059_100 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 8.88e-05 | 749 | 53 | 9 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 9.16e-05 | 936 | 53 | 10 | JC_hmvEC_2500_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_100 | 1.09e-04 | 99 | 53 | 4 | PCBC_ctl_PulmonMicrovasc_100 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 1.32e-04 | 456 | 53 | 7 | GSM777032_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_1000 | 1.35e-04 | 981 | 53 | 10 | PCBC_ctl_PulmonMicrovasc_1000 | |
| CoexpressionAtlas | Mesoderm Day 30_vs_Mesoderm Day 15-Confounder_removed-fold2.0_adjp0.05 | 1.36e-04 | 40 | 53 | 3 | PCBC_ratio_MESO-30_vs_MESO-15_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 1.38e-04 | 459 | 53 | 7 | GSM777037_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | ADAMTS19 RELN SCUBE1 DLL4 WNT7A WNT8B SCUBE3 SHISA2 LRP1B FBN3 | 1.48e-04 | 992 | 53 | 10 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_100 | 2.07e-04 | 46 | 53 | 3 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_100 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 2.14e-04 | 219 | 53 | 5 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#1_top-relative-expression-ranked_200 | 2.81e-04 | 51 | 53 | 3 | gudmap_developingKidney_e11.5_metaneph mesench_200_k1 | |
| CoexpressionAtlas | thyroid gland | 3.26e-04 | 240 | 53 | 5 | thyroid gland | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#3_top-relative-expression-ranked_500 | 3.91e-04 | 57 | 53 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 5.00e-04 | 62 | 53 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 5.09e-04 | 148 | 53 | 4 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_500 | 5.40e-04 | 411 | 53 | 6 | gudmap_developingKidney_e12.5_renal vesicle_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 6.27e-04 | 975 | 53 | 9 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_1000 | 6.41e-04 | 978 | 53 | 9 | PCBC_ctl_CardioEndothel_1000 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000 | 6.80e-04 | 986 | 53 | 9 | PCBC_ratio_ECTO_vs_SC_1000 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_500 | 6.92e-04 | 431 | 53 | 6 | gudmap_developingKidney_e11.5_metaneph mesench_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 6.92e-04 | 431 | 53 | 6 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_200 | 6.98e-04 | 161 | 53 | 4 | gudmap_developingKidney_e12.5_renal vesicle_200 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | 7.00e-04 | 990 | 53 | 9 | JC_hmvEC_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 7.05e-04 | 991 | 53 | 9 | PCBC_ECTO_fibroblast_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | 7.20e-04 | 994 | 53 | 9 | PCBC_EB_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.44e-04 | 437 | 53 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K2 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 7.65e-04 | 165 | 53 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.07e-04 | 293 | 53 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K3 | 9.08e-04 | 76 | 53 | 3 | gudmap_RNAseq_e15.5_Podocytes_2500_K3 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 9.28e-04 | 456 | 53 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_200 | 1.02e-03 | 79 | 53 | 3 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_200 | |
| CoexpressionAtlas | Stem Cells, SC.LT34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34-, Bone marrow, avg-3 | 1.05e-03 | 80 | 53 | 3 | GSM791102_100 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_1000 | 1.14e-03 | 850 | 53 | 8 | gudmap_developingKidney_e11.5_metaneph mesench_1000 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 1.17e-03 | 83 | 53 | 3 | GSM476663_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_100 | 1.21e-03 | 84 | 53 | 3 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#4_top-relative-expression-ranked_200 | 1.30e-03 | 86 | 53 | 3 | gudmap_developingKidney_e15.5_Endothelial cells_200_k4 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.34e-03 | 672 | 53 | 7 | JC_iEC_2500_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_inducedDefinitiveEndoderm_fromFibroblast-derived-iPSC_top-relative-expression-ranked_500 | 1.37e-03 | 492 | 53 | 6 | PCBC_DE_fibroblast_500 | |
| CoexpressionAtlas | Stem Cells, SC.ST34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34+, Bone marrow, avg-2 | 1.58e-03 | 92 | 53 | 3 | GSM791112_100 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-09 | 196 | 53 | 7 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-09 | 196 | 53 | 7 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.00e-09 | 200 | 53 | 7 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 4.00e-09 | 200 | 53 | 7 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 4.00e-09 | 200 | 53 | 7 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 5.46e-08 | 171 | 53 | 6 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.46e-08 | 171 | 53 | 6 | 3112d15f2a28cf4a71992db4971d960716dc1264 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 5.66e-08 | 172 | 53 | 6 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 6.71e-08 | 177 | 53 | 6 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.71e-08 | 177 | 53 | 6 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.65e-08 | 181 | 53 | 6 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.65e-08 | 181 | 53 | 6 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.17e-08 | 183 | 53 | 6 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 8.44e-08 | 184 | 53 | 6 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.44e-08 | 184 | 53 | 6 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-08 | 185 | 53 | 6 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.99e-08 | 186 | 53 | 6 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.99e-08 | 186 | 53 | 6 | b80aaeebc03a318052076d2f02c123f5ddc5e73a | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.99e-08 | 186 | 53 | 6 | 8a8ed1502542d4895cba3fd5d534256206578716 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.99e-08 | 186 | 53 | 6 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.89e-08 | 189 | 53 | 6 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-07 | 190 | 53 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.05e-07 | 191 | 53 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-07 | 191 | 53 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-07 | 191 | 53 | 6 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-07 | 192 | 53 | 6 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-07 | 192 | 53 | 6 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 193 | 53 | 6 | ba9a47e2dc01efa6d2a99b1631d4951fac2648d4 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 193 | 53 | 6 | 724bb613fa434add5b1c5586b629328f819fbdfe | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 193 | 53 | 6 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-07 | 193 | 53 | 6 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 193 | 53 | 6 | 737e540c72a3cfe8dbd4c0f139f7d729a166793a | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-07 | 194 | 53 | 6 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-07 | 194 | 53 | 6 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-07 | 194 | 53 | 6 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-07 | 195 | 53 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.19e-07 | 195 | 53 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.19e-07 | 195 | 53 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-07 | 195 | 53 | 6 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-07 | 195 | 53 | 6 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-07 | 196 | 53 | 6 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-07 | 196 | 53 | 6 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | proximal-Endothelial-Lymphatic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-07 | 197 | 53 | 6 | 8835961bd734a86063fd854cd2fb7028aefb7a72 | |
| ToppCell | proximal-Endothelial-Lymphatic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-07 | 197 | 53 | 6 | 8d79e747e344656e2bfc7fe872b4430dca941196 | |
| ToppCell | proximal-3-Endothelial-Lymphatic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-07 | 197 | 53 | 6 | 1c64e4eb9bfbaf5d6b4349642858f83a00d4d4c6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-07 | 197 | 53 | 6 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-07 | 197 | 53 | 6 | 488e85991c5e668afb7672942726d9295b8fc7d8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.30e-07 | 198 | 53 | 6 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.30e-07 | 198 | 53 | 6 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.34e-07 | 199 | 53 | 6 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 199 | 53 | 6 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 199 | 53 | 6 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.38e-07 | 200 | 53 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.38e-07 | 200 | 53 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.38e-07 | 200 | 53 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 3.78e-07 | 124 | 53 | 5 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 160 | 53 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 160 | 53 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 161 | 53 | 5 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 161 | 53 | 5 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.42e-06 | 162 | 53 | 5 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-06 | 165 | 53 | 5 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-06 | 165 | 53 | 5 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-06 | 165 | 53 | 5 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-06 | 165 | 53 | 5 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.65e-06 | 167 | 53 | 5 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.75e-06 | 169 | 53 | 5 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-06 | 170 | 53 | 5 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-06 | 170 | 53 | 5 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-06 | 170 | 53 | 5 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.96e-06 | 173 | 53 | 5 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-06 | 175 | 53 | 5 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-06 | 175 | 53 | 5 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.13e-06 | 176 | 53 | 5 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.13e-06 | 176 | 53 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.13e-06 | 176 | 53 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-06 | 176 | 53 | 5 | 27e6b3ae41068d6cfdda3d46da7df2a27567140e | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-06 | 176 | 53 | 5 | d6a5470af9592f34a741265f2ea9651c05c3add3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.19e-06 | 177 | 53 | 5 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-06 | 179 | 53 | 5 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.32e-06 | 179 | 53 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-06 | 180 | 53 | 5 | 178648429686e6d4e6f3aafc350130e819788ecf | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-06 | 180 | 53 | 5 | fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 180 | 53 | 5 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-06 | 180 | 53 | 5 | c2a8f61c806f6f6f47743e9f7c9700705db43386 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-06 | 181 | 53 | 5 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 181 | 53 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-06 | 181 | 53 | 5 | 2e15c46e8260bb04d8264478c19a707221996026 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 182 | 53 | 5 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 182 | 53 | 5 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 182 | 53 | 5 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-06 | 183 | 53 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-06 | 183 | 53 | 5 | 89727b4f65949ed2dce9d2e0228c79fe4280230c | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-06 | 183 | 53 | 5 | 113e6d8d4bb271be984af06cd6c22b180425dcfc | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-06 | 183 | 53 | 5 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-06 | 184 | 53 | 5 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 2.72e-06 | 185 | 53 | 5 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 185 | 53 | 5 | eeb6f55a6f79adf80247baa2c4b0df44553557ad | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 185 | 53 | 5 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 185 | 53 | 5 | de353368f4f6a7a0a66e391d586879876fbe2734 | |
| Computational | Metal / Ca ion binding. | 3.87e-06 | 133 | 35 | 6 | MODULE_324 | |
| Computational | Genes in the cancer module 236. | 2.50e-05 | 18 | 35 | 3 | MODULE_236 | |
| Computational | ECM and collagens. | 7.68e-05 | 225 | 35 | 6 | MODULE_47 | |
| Computational | Ovary genes. | 1.53e-04 | 368 | 35 | 7 | MODULE_1 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.22e-06 | 161 | 54 | 6 | 3556_DN | |
| Drug | 12-tungstophosphate | 5.52e-06 | 2 | 54 | 2 | CID006398471 | |
| Drug | AC1L1GUQ | 6.00e-06 | 50 | 54 | 4 | CID000003849 | |
| Drug | napabucasin | 1.62e-05 | 64 | 54 | 4 | ctd:C000621033 | |
| Drug | triple sulfa | 1.65e-05 | 3 | 54 | 2 | CID000060896 | |
| Disease | Hepatic ductular hypoplasia | 3.17e-06 | 2 | 53 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 3.17e-06 | 2 | 53 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 3.17e-06 | 2 | 53 | 2 | C1857761 | |
| Disease | Alagille Syndrome | 3.17e-06 | 2 | 53 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 3.17e-06 | 2 | 53 | 2 | cv:C0085280 | |
| Disease | Alagille Syndrome 1 | 3.17e-06 | 2 | 53 | 2 | C1956125 | |
| Disease | intraocular pressure measurement | 3.33e-06 | 509 | 53 | 8 | EFO_0004695 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 6.10e-06 | 20 | 53 | 3 | DOID:2921 (biomarker_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 9.49e-06 | 3 | 53 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 9.49e-06 | 3 | 53 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 9.49e-06 | 3 | 53 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 9.49e-06 | 3 | 53 | 2 | C1869114 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.48e-05 | 447 | 53 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Weill-Marchesani syndrome | 1.89e-05 | 4 | 53 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.89e-05 | 4 | 53 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | central corneal thickness | 1.91e-05 | 309 | 53 | 6 | EFO_0005213 | |
| Disease | cortical surface area measurement | ADAMTS19 RELN SCUBE1 FBN1 MCPH1 BAZ2B WNT7A JAG1 FBN3 LRP8 PDZD2 | 2.21e-05 | 1345 | 53 | 11 | EFO_0010736 |
| Disease | cortical thickness | 2.49e-05 | 1113 | 53 | 10 | EFO_0004840 | |
| Disease | factor VIII measurement, venous thromboembolism | 3.15e-05 | 34 | 53 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 8.80e-05 | 8 | 53 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | microcephaly (is_implicated_in) | 8.80e-05 | 8 | 53 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | Alzheimer's disease (is_implicated_in) | 9.45e-05 | 132 | 53 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | Gastrointestinal Hemorrhage | 1.13e-04 | 9 | 53 | 2 | C0017181 | |
| Disease | Malignant neoplasm of breast | 1.14e-04 | 1074 | 53 | 9 | C0006142 | |
| Disease | glaucoma | 1.71e-04 | 154 | 53 | 4 | MONDO_0005041 | |
| Disease | Marfan Syndrome | 1.72e-04 | 11 | 53 | 2 | C0024796 | |
| Disease | Ulcerative Colitis | 2.01e-04 | 63 | 53 | 3 | C0009324 | |
| Disease | dementia (is_implicated_in) | 2.07e-04 | 12 | 53 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | autistic disorder (is_marker_for) | 2.07e-04 | 12 | 53 | 2 | DOID:12849 (is_marker_for) | |
| Disease | FEV/FEC ratio | 3.09e-04 | 1228 | 53 | 9 | EFO_0004713 | |
| Disease | Proteinuria | 3.27e-04 | 15 | 53 | 2 | HP_0000093 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 4.08e-04 | 80 | 53 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | factor VIII measurement, Ischemic stroke | 5.31e-04 | 19 | 53 | 2 | EFO_0004630, HP_0002140 | |
| Disease | bipolar disorder (is_marker_for) | 5.31e-04 | 19 | 53 | 2 | DOID:3312 (is_marker_for) | |
| Disease | cortisol measurement | 5.89e-04 | 20 | 53 | 2 | EFO_0005843 | |
| Disease | birth weight | 7.42e-04 | 399 | 53 | 5 | EFO_0004344 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 7.82e-04 | 23 | 53 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 9.25e-04 | 25 | 53 | 2 | DOID:0050589 (implicated_via_orthology) | |
| Disease | corpus collosum mid-posterior volume measurement | 9.25e-04 | 25 | 53 | 2 | EFO_0010300 | |
| Disease | response to gemcitabine | 9.25e-04 | 25 | 53 | 2 | GO_0036272 | |
| Disease | body surface area | 1.01e-03 | 643 | 53 | 6 | EFO_0022196 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 1.03e-03 | 110 | 53 | 3 | EFO_0803335 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 1.08e-03 | 27 | 53 | 2 | EFO_0004629, EFO_0004630 | |
| Disease | corpus callosum central volume measurement | 1.16e-03 | 28 | 53 | 2 | EFO_0010296 | |
| Disease | corneal resistance factor | 1.28e-03 | 451 | 53 | 5 | EFO_0010067 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.33e-03 | 30 | 53 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | factor XI measurement, venous thromboembolism | 1.33e-03 | 30 | 53 | 2 | EFO_0004286, EFO_0004694 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 1.33e-03 | 30 | 53 | 2 | EFO_0004629, HP_0002140 | |
| Disease | Squamous cell carcinoma | 1.46e-03 | 124 | 53 | 3 | C0007137 | |
| Disease | vital capacity | 1.54e-03 | 1236 | 53 | 8 | EFO_0004312 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.59e-03 | 128 | 53 | 3 | DOID:4450 (is_marker_for) | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 1.61e-03 | 33 | 53 | 2 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | cervical cancer | 1.71e-03 | 34 | 53 | 2 | C4048328 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ACNQNQGRCYNGECK | 591 | O75077 | |
| GGGNRKCNQEQSKNQ | 206 | Q9UIF8 | |
| CFNGGSCRERNQGAN | 371 | Q9NR61 | |
| VDCGLDKSNCGKQQN | 596 | Q9NR61 | |
| QGCVDINECRVQNGG | 1151 | Q75N90 | |
| SDGFNGGCEQLCLQQ | 661 | O14525 | |
| CQLACGQDGQLKGFA | 251 | Q8IY67 | |
| GGGAALKENVCQNCE | 1536 | Q96L73 | |
| QGLDICANGRCQKVG | 751 | Q8TE59 | |
| CKNGVNGTGENGRKC | 401 | P05556 | |
| QGCGDRQLLQCGRNA | 176 | Q96LR9 | |
| NHRCQNGGVCVDGVN | 266 | Q04721 | |
| ICLDCLRNNGQSGDN | 141 | Q86SE9 | |
| KQQGDNMCRVNNGGC | 791 | Q9NZR2 | |
| DDLCGNSGCGNQERK | 236 | Q8NEM0 | |
| RLNGQGVCQIECGAQ | 3201 | O95714 | |
| DECQQGNLCVNGQCK | 1081 | Q14766 | |
| GNLCVNGQCKNTEGS | 1086 | Q14766 | |
| QAEECGILNGCENGR | 1621 | Q14766 | |
| KVCGLCGNNNGDLKD | 1406 | Q7Z5P9 | |
| SGDRCQLQTRCQNGG | 2976 | Q02505 | |
| ESDRRGGCLAQGNCQ | 2111 | O15018 | |
| GGCLAQGNCQEKSEI | 2116 | O15018 | |
| QCRNLGCINAQGKED | 101 | Q96PD4 | |
| QCEEMCNGQGSCING | 2131 | P78509 | |
| RIGNGQCKNQCHENE | 36 | Q30KQ9 | |
| GDIGALLKNFCGNCQ | 686 | Q14993 | |
| VCGLCGNMDRNPNND | 1811 | Q9Y6R7 | |
| AVCGLCGNMDRNPNN | 3011 | Q9Y6R7 | |
| QNGRICNNGRCINTD | 536 | P35555 | |
| VDECASGNGNLCRNG | 1931 | P35555 | |
| SGNGNLCRNGQCINT | 1936 | P35555 | |
| TNQCLDVGENNRGGK | 506 | Q8NCL4 | |
| NENLIAGCNIINGKC | 126 | Q9NZV1 | |
| GNALCGKLQCENVQE | 566 | Q13443 | |
| GLQAEECGILNGCEN | 1731 | Q14767 | |
| NGGQCNKKTGNCDCT | 116 | Q0D2K5 | |
| CQDNNGGCQQICVNA | 121 | Q8IWY4 | |
| QGACGAGQVLQDSKC | 616 | Q8IWY4 | |
| GNELNGGCVHDCLNI | 91 | Q9NQ36 | |
| VAQCKNRQCGGELGE | 796 | Q8IX30 | |
| AGCLQGLNECLHNNG | 331 | Q14114 | |
| NGELQNGNCCGGARN | 46 | P78504 | |
| GQCQNDASCRDLVNG | 456 | P78504 | |
| GDRCQLQTRCQNGGQ | 891 | Q9H195 | |
| NLCALCIGDEQGENK | 521 | P02788 | |
| ARLDQGGCDNDRQQG | 81 | Q6UWI4 | |
| AQDADIVCRCQGGNN | 51 | P30520 | |
| KECQHGGQCQVENGS | 356 | Q8TER0 | |
| NGECGDLLKACNNDS | 886 | O75443 | |
| NKVCGLCGNFNGDLT | 1616 | O75443 | |
| NCGCDDSRNGQLGGQ | 111 | Q93098 | |
| HNGGQLCDRTQCGEA | 111 | Q96MU6 | |
| KVCGLCGNFDGIQNN | 991 | P04275 | |
| FGADCRLQCQCQNGG | 311 | P35590 | |
| QKNCCEEGKEEQQGC | 666 | Q9H6E5 | |
| QRCGNGGRANCDASL | 416 | P40763 | |
| NGRTQCVDKNECQFG | 66 | Q6UWL2 | |
| NAQNVCFGNGICLDG | 1351 | Q8WWQ8 | |
| GNLSDCGCDKEKQGQ | 126 | O00755 | |
| RGGGQAQSKLQDGCN | 386 | Q9NY57 | |
| GSDEVNCKNVNQCLG | 306 | P98155 | |
| KECGTNECLDNNGGC | 311 | P01130 | |
| GQRKLCNGVNDCGDN | 326 | O75096 | |
| ENCNVNNGGCAQKCQ | 356 | O75096 | |
| NNGGCAQKCQMVRGA | 361 | O75096 |